SCI时时刷

search
Importance of Nutrition Security to CVD Prevention Efforts in the USA
Importance of Nutrition Security to CVD Prevention Efforts in the USA
The importance of addressing nutrition security for the primary and secondary prevention of cardiovascular disease (CVD) i...
Coconut Oil and Cardiovascular Disease Risk
Coconut Oil and Cardiovascular Disease Risk
This narrative review summarizes the current peer-reviewed literature and mechanisms surrounding the cardiovascular health...
New CRISPR Technology for Creating Cell Models of Lipoprotein Assembly and Secretion
New CRISPR Technology for Creating Cell Models of Lipoprotein Assembly and Secretion
This review is aimed at providing an overview of new developments in gene editing technology, including examples of how th...
Update on Sitosterolemia and Atherosclerosis
Update on Sitosterolemia and Atherosclerosis
The purpose of this review was to summarize important and updated information on sitosterolemia. Sitosterolemia is an inhe...
Structure-based mechanism and inhibition of cholesteryl ester transfer protein
Structure-based mechanism and inhibition of cholesteryl ester transfer protein
Cholesteryl ester transfer proteins (CETP) regulate plasma cholesterol levels by transferring cholesteryl esters (CEs) amo...
Genetic Testing in Familial Hypercholesterolemia: Is It for Everyone?
Genetic Testing in Familial Hypercholesterolemia: Is It for Everyone?
Lipid measurements and genetic testing are the main diagnostic tools for FH screening that are available in many countries...
The Cardiovascular Risks Associated with Aromatase Inhibitors, Tamoxifen, and GnRH Agonists in Women with Breast Cancer
The Cardiovascular Risks Associated with Aromatase Inhibitors, Tamoxifen, and GnRH Agonists in Women with Breast Cancer
Cardiovascular disease accounts for up to 10% of all-cause mortality in women with a diagnosis of breast cancer, and the c...
Is There a Role for Imaging Youth at Risk of Atherosclerosis?
Is There a Role for Imaging Youth at Risk of Atherosclerosis?
Cardiovascular (CV) risk factors such as dyslipidemia, hypertension, diabetes, and obesity are associated with an increase...
How Can Implementation Science Improve the Care of Familial Hypercholesterolaemia?
How Can Implementation Science Improve the Care of Familial Hypercholesterolaemia?
Describe the application of implementation science to improve the detection and management of familial hypercholesterolaem...
Does Coronary Plaque Morphology Matter Beyond Plaque Burden?
Does Coronary Plaque Morphology Matter Beyond Plaque Burden?
Imaging of adverse coronary plaque features by coronary computed tomography angiography (CCTA) has advanced greatly and at...
Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis
Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis
Clonal hematopoiesis (CH) is a prevalent condition that results from the acquisition of somatic mutations in hematopoietic...
Health Literacy is Essential to ASCVD Prevention in Youth
Health Literacy is Essential to ASCVD Prevention in Youth
Health literacy is fundamental to primary and primordial prevention of atherosclerotic vascular disease (ASCVD) in childre...
Benefit of Combination Ezetimibe/Simvastatin Among High-Risk Populations: Lessons from the IMPROVE-IT Trial
Benefit of Combination Ezetimibe/Simvastatin Among High-Risk Populations: Lessons from the IMPROVE-IT Trial
The Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) demonstrated the clinical benefit of...
Telomere Length: Implications for Atherogenesis
Telomere Length: Implications for Atherogenesis
The purpose of the study is to explore the evidence linking telomere length with atherosclerotic ischemic disease. There h...
APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism
APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism
Apolipoprotein C-III (ApoC-III) is a widely known player in triglyceride metabolism, and it has been recently recognized a...
Apheresis: What Should a Clinician Know?
Apheresis: What Should a Clinician Know?
Apheresis is a treatment option for severe dyslipidemia which has been introduced approximately 40 years ago to c...
How ANGPTL3 Inhibition Will Help Our Clinical Practice?
How ANGPTL3 Inhibition Will Help Our Clinical Practice?
This review aims to summarize the most recently published literature highlighting the potential of pharmacological inhibit...
The Management of Hypercholesterolemia in Patients with Neuromuscular Disorder
The Management of Hypercholesterolemia in Patients with Neuromuscular Disorder
We describe and discuss the safety of statins and non-statin drugs in neuromuscular disorders (NMDs). We also propose a pr...
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American Heart Association Scientific Sessions
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American Heart Association Scientific Sessions
Summarize selected late-breaking science on cardiovascular (CV) disease prevention presented at the 2022 scientific sessio...
From ‘Omics to Multi-omics Technologies: the Discovery of Novel Causal Mediators
From ‘Omics to Multi-omics Technologies: the Discovery of Novel Causal Mediators
‘Omics studies provide a comprehensive characterisation of a biological entity, such as the genome, epigenome, trans...
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues
The omega-3 fatty acids (n3-FAs), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have recently undergone test...
Social Media and Cardiovascular Health: Implications for Women
Social Media and Cardiovascular Health: Implications for Women
Cardiovascular disease (CVD) is the leading cause of mortality in adult women in the USA, yet CVD is underrecognized in wo...
CETP Inhibitors: Should We Continue to Pursue This Pathway?
CETP Inhibitors: Should We Continue to Pursue This Pathway?
For more than 20 years there has been considerable interest in the development of pharmacological inhibitors of c...
The Dynamic Interplay of Healthy Lifestyle Behaviors for Cardiovascular Health
The Dynamic Interplay of Healthy Lifestyle Behaviors for Cardiovascular Health
The recent rise in cardiovascular disease (CVD) deaths in the USA has sparked interest in identifying and implementing eff...
Transitioning to GLP-1 RAs and SGLT2 Inhibitors as the First Choice for Managing Cardiometabolic Risk in Type 2 Diabetes
Transitioning to GLP-1 RAs and SGLT2 Inhibitors as the First Choice for Managing Cardiometabolic Risk in Type 2 Diabetes
This forward-looking review summarizes existing evidence from cardiovascular outcome trials on cardiometabolic risk-reduct...
PCSK9 Inhibition and Risk of Diabetes: Should We Worry?
PCSK9 Inhibition and Risk of Diabetes: Should We Worry?
Since the clinical benefit of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors occurs in a setting of redu...
Pregnancy Loss and Cardiovascular Diseases in Women: Recent Findings and Potential Mechanisms
Pregnancy Loss and Cardiovascular Diseases in Women: Recent Findings and Potential Mechanisms
Pregnancy loss (PL) has been acknowledged by the American Heart Association as a risk factor for cardiovascular diseases (...
A Contemporary Review of Epidemiology, Risk Factors, Etiology, and Outcomes of Premature Stroke
A Contemporary Review of Epidemiology, Risk Factors, Etiology, and Outcomes of Premature Stroke
Recent data identifies increases in young ischemic and hemorrhagic strokes. We provide a contemporary overview of current ...